UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
---|---|---|---|---|
Q2FVX9 (MOAC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Cyclic pyranopterin monophosphate synthase; Molybdenum cofactor biosynthesis protein C; | |
Q2FUW9 (SASF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Surface protein F; | |
Q2FW38 (RL13_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Large ribosomal subunit protein uL13; 50S ribosomal protein L13; | |
Q2FY55 (Y1610_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Bacilliredoxin SAOUHSC_01610; | |
Q2FYK4 (Y1436_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Bacilliredoxin SAOUHSC_01436; | |
Q2G2E1 (MNHG2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative antiporter subunit mnhG2; Mrp complex subunit G2; Putative NADH-ubiquinone oxidoreductase subunit mnhF2; | |
Q2FVQ7 (Y2645_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Uncharacterized HTH-type transcriptional regulator SAOUHSC_02645; | |
P72358 (LRGA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Antiholin-like protein LrgA; | |
Q2G0B1 (MGRA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | HTH-type transcriptional regulator MgrA; Regulator of autolytic activity; | |
Q2FXG2 (RISB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 6,7-dimethyl-8-ribityllumazine synthase; | |
Q2FXY7 (LEPA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Elongation factor 4; Ribosomal back-translocase LepA; | |
Q2FYG7 (NDK_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Nucleoside diphosphate kinase; Nucleoside-2-P kinase; | |
Q2FWV5 (CHIPS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Chemotaxis inhibitory protein; CHIPS; | |
Q2FUQ3 (MNMG_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG; Glucose-inhibited division protein A; | |
Q2G2K8 (UREE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Urease accessory protein UreE; | |
Q2FXU2 (DTD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | D-aminoacyl-tRNA deacylase; Gly-tRNA(Ala) deacylase; | |
Q2FY49 (ARGR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Arginine repressor; | |
Q2G2T3 (RL9_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Large ribosomal subunit protein bL9; 50S ribosomal protein L9; | |
Q2G222 (Y2979_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | N-acetylmuramoyl-L-alanine amidase domain-containing protein SAOUHSC_02979; | |
Q2G1M8 (SBNF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 2-[(L-alanin-3-ylcarbamoyl)methyl]-3-(2-aminoethylcarbamoyl)-2-hydroxypropanoate synthase; Staphyloferrin B biosynthesis protein SbnF; | |
Q2G282 (PERR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Peroxide-responsive repressor PerR; | |
Q2FVN3 (SARZ_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | HTH-type transcriptional regulator SarZ; Staphylococcal accessory regulator Z; | |
P0A0F8 (RL15_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Large ribosomal subunit protein uL15; 50S ribosomal protein L15; | |
Q2FWF5 (FABZ_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase; Beta-hydroxyacyl-ACP dehydratase; | |
Q2FZF5 (COAD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Phosphopantetheine adenylyltransferase; Dephospho-CoA pyrophosphorylase; Pantetheine-phosphate adenylyltransferase; | |
Q2G210 (MNHE2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative antiporter subunit mnhE2; Mrp complex subunit E2; Putative NADH-ubiquinone oxidoreductase subunit mnhE2; | |
Q53705 (LYTS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Sensor histidine kinase/phosphatase LytS; Autolysin sensor kinase; | |
Q2G1N1 (SBNC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Staphyloferrin B synthase; Staphyloferrin B biosynthesis protein SbnC; | |
Q2FXM9 (KPYK_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Pyruvate kinase; | |
Q2FV11 (BETA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Oxygen-dependent choline dehydrogenase; Betaine aldehyde dehydrogenase; | |
Q2G2K5 (URE1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Urease subunit alpha; Urea amidohydrolase subunit alpha; | |
Q2G178 (ESSG_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Type VII secretion system protein EsaG; | |
Q2FZ79 (LSPA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Lipoprotein signal peptidase; Prolipoprotein signal peptidase; Signal peptidase II; | |
Q2G1M9 (SBNE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | L-2,3-diaminopropanoate--citrate ligase; Staphyloferrin B biosynthesis protein SbnE; | |
Q2G2H8 (MNHE1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Na(+)/H(+) antiporter subunit E1; Mnh complex subunit E1; | |
Q2FZD0 (UVRC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UvrABC system protein C; Excinuclease ABC subunit C; | |
Q2FW84 (MDEP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Multidrug resistance efflux pump SepA; Antiseptic resistance protein SepA; Staphylococcal efflux pump A; | |
P0A0Q4 (Y996_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Uncharacterized protein SAOUHSC_00996; ORF2; | |
Q2FXP3 (NRDR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Transcriptional repressor NrdR; | |
Q2FWC3 (LUXS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | S-ribosylhomocysteine lyase; AI-2 synthesis protein; Autoinducer-2 production protein LuxS; | |
P48940 (RS7_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Small ribosomal subunit protein uS7; 30S ribosomal protein S7; | |
Q2FXF2 (SIGS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | RNA polymerase sigma factor SigS; | |
Q2FXW7 (GREA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Transcription elongation factor GreA; Transcript cleavage factor GreA; | |
Q2G2D3 (RIMP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribosome maturation factor RimP; | |
Q2FY02 (YBEY_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Endoribonuclease YbeY; | |
Q2FV54 (OATA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | O-acetyltransferase OatA; | |
Q2FUU0 (HIS7_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Imidazoleglycerol-phosphate dehydratase; | |
Q2G0Y9 (XPT_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Xanthine phosphoribosyltransferase; | |
Q2FWK3 (LEU1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 2-isopropylmalate synthase; Alpha-IPM synthase; Alpha-isopropylmalate synthase; | |
Q2G0L7 (AZO1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | FMN-dependent NADPH-azoreductase; NADPH-dependent flavo-azoreductase; NADPH-flavin azoreductase; |
Staphylococcus aureus is a Gram-positive coccal bacterium that is a member of the Firmicutes, and is frequently found in the nose, respiratory tract, and on the skin. Although S. aureus is not always pathogenic, it is a common cause of skin infections such as abscesses, respiratory infections such as sinusitis, and food poisoning.
An estimated 20% of the human population are long-term carriers of S. aureus. It is one of the five most common causes of hospital-acquired infections and is often the cause of postsurgical wound infections. The emergence of antibiotic-resistant strains of S. aureus such as methicillin-resistant S. aureus (MRSA) is a worldwide problem in clinical medicine. There are currently (2016) no dedicated antibiotics against drug-resistant S. aureus available.
The genome of S. aureus was first sequenced in 2006.
From left to right: i) The number of proteins in the reference proteome of Staphylococcus aureus, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Staphylococcus aureus for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Staphylococcus aureus, please visit UniProtKB.
You can easily download the latest protein sequences for Staphylococcus aureus proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2025_02 that was used for the most up to date SWISS-MODEL Repository.
Proteins in proteome | Sequences modelled | Models |
2,889 | 2,385 | 3,920 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Staphylococcus aureus reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Staphylococcus aureus proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 12-mer | 13-mer | 14-mer | 24-mer | 25-mer | 40-mer | 60-mer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,480 | 1,003 | 84 | 205 | 5 | 79 | 6 | 15 | 3 | 8 | 13 | 3 | 5 | 8 | 1 | 1 | 1 |